Physician profile

Pardeep Sandhu

Family · Stockton, CA

NPI 1366108698

$670.58

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$670.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Pfizer INC. $157.09 2023
Abbvie INC. $148.34 2024
Amgen INC. $76.76 2024 Otezla
Lilly USA, LLC $49.00 2024 Olumiant, Taltz
Esperion Therapeutics, INC. $46.72 2023-2024 Nexletol
Leo Pharma INC. $45.22 2024 Adbry
E.R. Squibb & Sons, L.L.C. $36.32 2024 Sotyktu
Novartis Pharmaceuticals Corporation $35.22 2024
Janssen Scientific Affairs, LLC $28.77 2023 Symtuza
Dermavant Sciences, INC. $24.09 2023 Vtama
Regeneron Healthcare Solutions, INC. $23.05 2024 Dupixent

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Pardeep Sandhu

$670.58

in general payments reported 2019-2025

Years
2023-2024
Top company
Pfizer INC.

https://glasscript.com/doctor/11264962/pardeep-sandhu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.